DIAGNOS Inc.
DIAGNOS Inc. (DGNOF) Financial Performance & Income Statement Overview
Review DIAGNOS Inc. (DGNOF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
DIAGNOS Inc. (DGNOF) Income Statement & Financial Overview
Analyze DIAGNOS Inc.’s DGNOF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $18392.00 | $26042.00 | $22673.00 | $36690.00 |
| Cost of Revenue | $308684.00 | $300672.00 | $312199.00 | $125803.00 |
| Gross Profit | -$290292.00 | -$274630.00 | -$289526.00 | -$89113.00 |
| Gross Profit Ratio | -$15.78 | -$10.55 | -$12.77 | -$2.43 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.007M | $794023.00 | $590202.00 | $488955.00 |
| Operating Expenses | $994352.00 | $794023.00 | -$289526.00 | $488955.00 |
| Total Costs & Expenses | $1.30M | $1.09M | $902401.00 | $614758.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $152354.00 | $150834.00 | $145889.00 | $144873.00 |
| Depreciation & Amortization | $31484.00 | $32936.00 | $32226.00 | $31782.00 |
| EBITDA | -$1.15M | -$1.03M | -$841217.00 | -$539811.00 |
| EBITDA Ratio | -$62.71 | -$39.53 | -$37.10 | -$14.71 |
| Operating Income | -$1.28M | -$1.07M | $0.00 | -$578068.00 |
| Operating Income Ratio | -$69.85 | -$41.04 | $0.00 | -$15.76 |
| Other Income/Expenses (Net) | -$52579.00 | -$144585.00 | -$1.02M | -$138588.00 |
| Income Before Tax | -$1.34M | -$1.21M | -$1.02M | -$716656.00 |
| Income Before Tax Ratio | -$72.71 | -$46.59 | -$44.96 | -$19.53 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$1.34M | -$1.21M | -$1.02M | -$716656.00 |
| Net Income Ratio | -$72.71 | -$46.59 | -$44.96 | -$19.53 |
| EPS | -$0.01 | -$0.01 | -$0.01 | -$0.009 |
| Diluted EPS | -$0.01 | -$0.01 | -$0.01 | -$0.009 |
| Weighted Avg Shares Outstanding | $101.86M | $93.73M | $82.35M | $77.98M |
| Weighted Avg Shares Outstanding (Diluted) | $101.86M | $93.73M | $82.35M | $77.98M |
Over the last four quarters, DIAGNOS Inc.'s revenue moved from $36690.00 in Q1 2024 to $18392.00 in Q4 2024. Operating income in Q4 2024 was -$1.28M, with a strong operating margin of -6985%. Despite fluctuations in R&D and SG&A expenses, EBITDA for DIAGNOS Inc. remained robust at -$1.15M, reflecting operational efficiency. Net income dropped to -$1.34M, with an EPS of -$0.01. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan